F.D.A. Approves Moderna’s mRNA Flu Vaccine
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (12)
- FDA approves first mRNA-based flu vaccine kcci.com · 1d ago
- FDA approves Moderna's mRNA seasonal flu vaccine ABC7 New York · 1d ago
- Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio Fierce Pharma · 1d ago
- FDA Approves First MRNA Flu Vaccine For Older Adults Forbes · 1d ago
- FDA approves Moderna's mRNA seasonal flu vaccine ABC News - Breaking News, Latest News and Videos · 1d ago
- New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine PBS · 1d ago
- Pa. experts welcome FDA approval of Moderna’s mRNA flu vaccine TribLIVE.com · 1d ago
- A new flu vaccine geared to older people is coming soon NPR · 1d ago
- The mRNA technology behind Moderna’s Covid vaccine reaches the flu The Guardian · 1d ago
- New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine AP News · 1d ago
- FDA approves Moderna's mRNA flu vaccine after initial pushback CBS News · 1d ago
- US FDA approves first mRNA flu shot from Moderna Reuters · 1d ago broke it first
Related trends
Wendy’s Withdraws Outlook, Slashes Dividend as Turnaround Struggles to Take Hold
Wendy's has withdrawn its financial outlook and halved its dividend amid falling sales and traffic headwinds.
Rockstar Energy founder builds Celsius stake, wants to take over as CEO
The founder of Rockstar Energy acquires a significant stake in Celsius and seeks to become CEO.
China's exports growth beats estimates in July, as AI-driven shipments surge
China's exports jumped almost a quarter in July, driven by a surging tech cycle and strong demand for artificial intelligence shipments.
Meta told to pay another $567m in New Mexico child safety lawsuit
Meta faces a massive court-ordered payout over child safety and mental health online.
Trump announces tariffs on key component for solar panels and semiconductors
Trump imposes a 15% tariff and sets minimum prices on key semiconductor and solar panel materials.
Sweetgreen cuts full-year outlook as cyclospora fears weigh on sales
Sweetgreen slashed its full-year outlook and lowered Q3 projections after a cyclospora outbreak derailed its sales recovery and widened losses.